ioversol has been researched along with HbS Disease in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To review adverse outcomes following contrast administration in a cohort of patients with sickle cell disease." | 1.38 | Safety of iodinated intravenous contrast medium administration in sickle cell disease. ( Adams, S; Andrel, J; Axelrod, D; Ballas, SK; Campbell, KL; Feldman, AM; Hud, LM, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, KL | 1 |
| Hud, LM | 1 |
| Adams, S | 1 |
| Andrel, J | 1 |
| Ballas, SK | 1 |
| Feldman, AM | 1 |
| Axelrod, D | 1 |
1 other study available for ioversol and HbS Disease
| Article | Year |
|---|---|
Safety of iodinated intravenous contrast medium administration in sickle cell disease.
Topics: Adult; Anemia, Sickle Cell; Contrast Media; Female; Humans; Infusions, Intravenous; Male; Middle Age | 2012 |